12,372 trials
Diphtheria · Pertussis · Tetanus
Primary: Immunogenicity - Seroprotection (Seroconversion for Pertussis) to Each Vaccine Component — 93.1; 99.2; 98.5; 93.1 percentage of subjects
Multiple Myeloma
Primary: The Number of Participants Experiencing a Response to the Peptide Vaccines. — 2 participants
Caries
Primary: Percentage Surface Microhardness Recovery (%SMHR) of Sound Enamel Specimens Exposed to NaF Toothpaste (1450ppmF) and NaF Toothpaste (1400ppmF) — 28.31; 26.32 Percentage…
Heart Failure
Primary: Change in Serum Creatinine — -0.04; 0.23 mg/dL
Infections, Rotavirus
Primary: Number of Subjects With Severe Episode(s) of Rotavirus Gastroenteritis (RVGE) Caused by the Circulating Wild Type (WT) Strains — 21; 75 Participants
Breast Cancer · Hot Flashes
Primary: Number of Daily Hot Flashes — 5; 4.5 daily hot flashes
Attention-Deficit/Hyperactivity Disorder
Primary: Time to First Response — 12.0; 21.0 Days — p==0.001
Hepatitis C, Chronic
Primary: Percentage of Participants With a Sustained Virologic Response 24 Weeks After Scheduled Completion of Treatment — 52; 57 percentage of participants — p=0.4557
Rheumatoid Arthritis
Primary: Mean Change From Baseline in Global Power Doppler Ultrasonography (PDUS) Score Assessing the Metacarpophalangeal (MCP) 2-5 Joints of Both Hands (LOCF Analysis) — -0.7…
Schizophrenia
Primary: Change From Baseline in the Positive and Negative Syndrome Scale (PANSS) Total Score at Day 56 — 89.6; 92.0; -19.3; -19.8 Units on a scale — p=0.935
Healthy
Primary: Number of Brain Scans in Healthy Young Adults Subjects Which do Not Show Amyloid — 181; 0; 123; 58 Brain Scans Read
Non-Hodgkin's Lymphoma · Lymphoma
Primary: Percentage Change in Bone Mineral Density (BMD) T-Score From Baseline to 12 Months — 0.08; -0.09 Percentage Change of BMD
Pain, Postoperative
Primary: Sum of Pain Intensity Difference (SPID) at Hour 48 — 32.5; 37.2 Units on scale — p=0.1648
Chronic Pain
Primary: Change From Baseline in Visual Analogue Scale (VAS24) Score at Week 4 — 65.80; -22.28 millimeter
Cataracts · Inflammation
Primary: Percentage of Patients With an Anterior Cell Grade of 0 (no Cells) at Day 15 ± 2 Days — 78.9; 77.5 Percentage of patients